The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSALV.L Regulatory News (SALV)

  • There is currently no data for SALV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Operational Update

11 Dec 2012 07:00

RNS Number : 2193T
3Legs Resources plc
11 December 2012
 



For Immediate Release

 

11 December 2012

 

 

3Legs Resources plc

 

Operations on Baltic Basin concessions in northern Poland

 

3Legs Resources plc (the "Company"), an independent oil and gas group focusing on the exploration and development of unconventional oil and gas resources, announces the following operational update.

 

Highlights

 

·; Substantially improved performance achieved on the further testing of Lebien LE-2H horizontal well

·; Drilling of the Strzeszewo LE-1 vertical well, the Company's fifth well in the Baltic Basin, completed; extensive suite of logs has been run on the well, data now undergoing processing and analysis

·; Preparations continuing for the Company's previously-announced 2013 drilling programme

 

Operational update

 

Further testing of Lebien LE-2H horizontal well

 

·; During further testing, the Lebien LE-2H horizontal well flowed natural gas from the Ordovician horizon for a 21-day natural flow test, without any artificial lift, flowing at an average rate of 550 mscf/d through 3½ inch tubing from 31 October to 21 November 2012, when testing was suspended.

·; Immediately prior to suspension of the test, the well was flowing natural gas at a rate of 470 mscf/d. A total of 12 mmscf of natural gas was produced over the test period.

·; The well continued to clean up throughout the test period; by the end of the test, approximately 29.4% of the water used during the hydraulic fracturing operation on the well in 2011 had been recovered.

·; The results of this further testing represent a significant improvement on the result achieved when the well was first tested in 2011. On that occasion, the well flowed with the assistance of a nitrogen lift at a rate of between 450 and 520 mscf/d over an 8-day period, prior to being shut in.

·; The well is now in a planned shut in period to record pressure build-up using surface and downhole pressure gauges; this pressure build up data will further enhance understanding of the longer term flow potential of the Ordovician interval.

·; The plan is to continue to gather additional data on well performance, with a view to making a decision on any future operations on the well in Q1 2013 following recovery of the pressure gauges.

 

Strzeszewo LE-1 vertical well

 

·; Drilling of the Strzeszewo LE-1 vertical well has now been completed; the well was drilled to 3060 metres true vertical depth into the Middle Cambrian interval.

·; Some 220 metres of whole core have been recovered from the well over the Lower Silurian, Ordovician, and Cambrian intervals, for analysis.

·; An extensive suite of logs has also been run on the well, and these are now undergoing processing and analysis.

·; Preliminary log analysis indicates that the well encountered a thicker Ordovician section as compared with the Lebien LE-1 and Warblino LE-1 vertical wells. The precise thickness will be determined following final processing and analysis of the logs over the coming weeks, but the preliminary data confirm the Company's earlier modelling of the development of the Ordovician interval across the northern portions of its western Baltic Basin concessions.

·; Preliminary log analysis also indicates that the thickness of the Upper Cambrian interval is similar to that encountered at the Warblino LE-1 vertical well. Again, exact figures will be confirmed once final log processing and analysis is completed over the next few weeks. As the Lebien LE-1 well only targeted shallower zones, Upper Cambrian data were not taken from this well.

·; The Strzeszewo LE-1 well has now been cased and cemented, and the rig has been released. A diagnostic formation injection test ("DFIT") is currently being planned, with expected execution in early 2013.

·; Options being considered for further testing of this well include DFITs and/or hydraulic frac testing.

·; Further announcements will be made in due course.

 

Further wells in 2013

 

·; Preparations are continuing for the Company's previously-announced drilling programme for 2013, involving the drilling, coring and logging of two or more vertical wells on the Company's high graded acreage on its western Baltic Basin concessions.

·; As previously announced, these wells will be designed with the option to drill and test horizontal sections at a later stage.

·; The 2013 drilling programme is expected to result in a significant further de-risking of the Company's western Baltic Basin acreage.

 

Kamlesh Parmar, Chief Executive of 3Legs Resources,said:

 

"The substantially improved performance achieved on the further testing of the Lebien LE-2H horizontal well is very encouraging. The well has succeeded in flowing unassisted and at a sustained rate for a three-week period, while continuing to clean up; and early indications are that our target formation may have additional reservoir potential. An average rate of 550 mmscf/d over a 21-day period is a big step in the right direction, given that the lateral section on the well is no more than 1,000 metres in length and comprised 13 frac stages, whereas it will be quite possible to drill future horizontal wells with significantly longer lateral sections and more frac stages. We will continue to analyse the results of the well test and the pressure data so as to consider any additional steps which may potentially improve performance both from this well and future wells.

 

We are also very pleased that our fifth well in the Baltic Basin, the Strzeszewo LE-1 vertical well, has now been drilled, cased and cemented. Preliminary results from the well indicate an increasing thickness in the Ordovician section as one moves north in our western Baltic Basin concessions. This further validates our geological model for the basin as a whole, and confirms our modelling of our high-graded area across the northern part of our western Baltic Basin concessions. The well has yielded a wealth of additional core and log data which will enable us, after analysis, to determine the optimum programme for further evaluation of individual target intervals. With the first DFIT being planned for the New Year, we expect the remainder of the testing programme for this well to take shape in early 2013."

 

 

For further information contact:

 

3Legs Resources plc

Tel:

+44 1624 811 611

Kamlesh Parmar, Chief Executive Officer

Alexander Fraser, Chief Financial Officer

Jefferies Hoare Govett

Tel:

+44 207 029 8000

Simon Hardy

Jamie Buckland

College Hill

Tel:

+44 207 457 2020

Matthew Tyler

Catherine Wickman

 

 

Notes to Editors

 

3Legs Resources was established in early 2007 to focus on the exploration and development of unconventional oil and gas resources. A first mover in Poland, 3Legs Resources holds interests in six licences covering approximately 1,084,000 acres (gross) in the onshore Baltic Basin in northern Poland, a region considered to be one of the most promising shale basins in Europe. The Company also holds onshore exploration licences near Krakow in southern Poland and has licences in Baden-Württemberg in south-west Germany which are currently undergoing renewal.

 

The technical information and opinions contained in this announcement have been reviewed by John Blair (MSc in Geophysics, University of Tulsa and BSc in Geology from Montana State University), Exploration Manager of 3Legs Resources plc, who has over 25 years of experience in the oil exploration and production industry. He has consented to the inclusion herein of such technical information and opinions.

 

www.3legsresources.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDMMMZVMLGZZG
Date   Source Headline
9th Jan 20202:30 pmRNSCancellation of trading on AIM
20th Dec 201910:30 amRNSCancellation of AIM listing /Potential acquisition
27th Sep 201911:07 amRNSHalf-year Report - Correction
26th Sep 20192:06 pmRNSHalf-year Report
23rd Sep 20193:02 pmRNSAIM Rule 17 Notification
9th Jul 20197:30 amRNSSuspension - SalvaRx Group Plc
9th Jul 20197:30 amRNSSuspension of Trading
28th Jun 201911:26 amRNSFinal Results
31st Jan 20197:00 amRNSChange of Nominated Adviser and Broker
17th Jan 20192:05 pmRNSSecond Price Monitoring Extn
17th Jan 20192:00 pmRNSPrice Monitoring Extension
8th Jan 20194:15 pmRNSResult of AGM and Completion of Disposal
4th Jan 20195:30 pmRNSSalvarx Group
14th Dec 20187:50 amRNSNominated Adviser Status
10th Dec 20187:00 amRNSIssue of US$1 million of Loan Notes by iOx
27th Nov 20187:00 amRNSPosting of Circular and Notice of AGM
21st Nov 20181:00 pmRNSTransaction Update
6th Nov 20187:00 amRNSDirector/PDMR Dealing
22nd Oct 20189:47 amRNSIntensity Therapeutics Update
9th Oct 20187:00 amRNSExercise of Warrants
27th Sep 20187:00 amRNSHalf-year Report
28th Aug 20185:40 pmRNSUpdate re proposed disposal and demerger
14th Aug 20187:00 amRNSProposed disposal of interest in SalvaRx Limited
1st Aug 20184:40 pmRNSSecond Price Monitoring Extn
1st Aug 20184:35 pmRNSPrice Monitoring Extension
23rd Jul 20181:17 pmRNSDelay in iOx development programme
28th Jun 20187:00 amRNSFinal Results
26th Jun 20187:00 amRNSRelated Party Loan of US$1 million
8th Mar 201812:00 pmRNSDrug Pipeline Progress and iOx Loan Note Issue
30th Oct 20174:40 pmRNSSecond Price Monitoring Extn
30th Oct 20174:35 pmRNSPrice Monitoring Extension
23rd Oct 20177:00 amRNSSubscriptions for SalvaRx Ltd Loan Facility
27th Sep 20179:00 amRNSHalf-year Report
25th Sep 20178:00 amRNSFormation of Saugatuck Therapeutics
1st Aug 20173:30 pmRNSHolding(s) in Company
1st Aug 20173:30 pmRNSHolding(s) in Company
31st Jul 20171:45 pmRNSResult of AGM
5th Jul 20173:03 pmRNSNotice of AGM
30th Jun 20178:34 amRNSFinal Results
30th May 201712:45 pmRNSIntensity Therapeutics Treats First Patient
20th Mar 20177:00 amRNSInvestment in Rift Biotherapeutics
2nd Mar 20177:00 amRNSRestructuring, Loan Conversion and Loan Facility
28th Feb 20177:00 amRNSInvestment in Nekonal
2nd Feb 20174:37 pmRNSIntensity Therapeutics
3rd Oct 20164:40 pmRNSSecond Price Monitoring Extn
3rd Oct 20164:35 pmRNSPrice Monitoring Extension
14th Sep 20167:00 amRNSCorporate Video
13th Sep 20167:00 amRNSHalf-year Report
22nd Aug 20167:00 amRNSDrug Pipeline Progress including Patent Grants
4th Aug 20162:05 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.